LMR Partners’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,178
Closed -$535K 1468
2022
Q3
$535K Buy
2,178
+891
+69% +$241K 0.01% 853
2022
Q2
$319K Buy
+1,287
New +$347K 0.01% 1001
2021
Q3
Sell
-1,261
Closed -$394K 1277
2021
Q2
$394K Buy
+1,261
New +$387K 0.01% 719
2021
Q1
Sell
-1,089
Closed -$353K 1094
2020
Q4
$353K Buy
+1,089
New +$301K 0.01% 376
2020
Q3
Sell
-20,754
Closed -$5.01M 672
2020
Q2
$5.01M Buy
+20,754
New +$4.17M 0.12% 107
2020
Q1
Sell
-4,170
Closed -$711 471
2019
Q4
$711 Buy
+4,170
New +$773K ﹤0.01% 262
2016
Q3
Sell
-28,996
Closed -$3.17M 521
2016
Q2
$3.17M Buy
+28,996
New +$2.88M 0.49% 49

Other funds holding ABMD

LMR Partners's ABMD Position: Q4 2022 in Review

LMR Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,178 shares — an estimated $535K sold.

LMR Partners first reported a position in ABMD in Q2 2016 and held it in 7 quarters. The position peaked at $5.01M in Q2 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • LMR Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • LMR Partners sold 2,178 Abiomed Inc shares in Q4 2022, an estimated $535K.
  • LMR Partners first reported a position in Abiomed Inc in Q2 2016 and held it in 7 quarters.
  • LMR Partners's Abiomed Inc position peaked at $5.01M in Q2 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.